Utama › Jangkitan Virus › Maryland
Kajian klinikal Jangkitan Virus di Maryland
14 kajian untuk Jangkitan Virus sedang mencari peserta di lokasi di Maryland.
Bandar di Maryland
Teks kajian rasmi (Bahasa Inggeris)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Annapolis
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05624450Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
- National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 120 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT00006518The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise
- National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaKajian pemerhatian
Umur 2 hingga 100 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT01011712A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Centennial Medical Group, Columbia
- Jadestone Clinical Research, Silver Spring
Mengambil pesertaFasa 3
Umur 12 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06679140A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Johns Hopkins Hospital, Baltimore
- Jadestone Clinical Research, Silver Spring
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07013474Phase 1 Challenge Study Using rDEN2delta30-7169 to Evaluate Host-Pathogen Interactions in Primary, Homotypic, and Heterotypic Dengue Virus Infection
- National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
Umur 18 hingga 50 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07706686Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions
- University of Maryland, Baltimore
Mengambil pesertaFasa 2
Umur 18 hingga 65 · Semua jantina · Dikemas kini 24 Sep 2026 · NCT07654283Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults
- National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
Umur 18 hingga 50 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT06863142Viral Infections in Healthy and Immunocompromised Hosts
- National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
6 Months – 120 Years · Semua jantina · Dikemas kini 14 Sep 2026 · NCT01306084Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity
- National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
2 Months – 115 Years · Semua jantina · Dikemas kini 10 Sep 2026 · NCT04419870Genetic Studies of Chronic Active Epstein-Barr Disease
- National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaKajian pemerhatian
Umur 1 hingga 120 · Semua jantina · Dikemas kini 28 Jul 2026 · NCT00032513Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)
- Johns Hopkins, Baltimore
Mengambil pesertaFasa 1/2
1 Month – 79 Years · Semua jantina · Dikemas kini 15 Apr 2026 · NCT04197596Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts
- Johns Hopkins University, Baltimore
- National Institutes of Health (NIH), Bethesda
Mengambil pesertaFasa 1
3 Months – 80 Years · Semua jantina · Dikemas kini 26 Jan 2026 · NCT04691622Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID)
- All Natural Medicine Clinic, LLC, Rockville
Mengambil pesertaFasa 1/2
Semua umur · Semua jantina · Dikemas kini 19 Feb 2025 · NCT04790240Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.